Prot #CP543.3001: A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate The Efficacy and Safety of CTP-543 in Adult Patients with Moderate to Severe Alopecia Areata

Project: Research project

Project Details

StatusActive
Effective start/end date3/25/21 → 3/25/24

Funding

  • Rho, Inc. (Prot #CP543.3001)
  • Concert Pharmaceuticals, Inc. (Prot #CP543.3001)